BMRN
Biomarin Pharmaceutical Inc
NASDAQ: BMRN · HEALTHCARE · BIOTECHNOLOGY
$54.21
+1.71% today
Updated 2026-04-29
Market cap
$10.48B
P/E ratio
30.12
P/S ratio
3.25x
EPS (TTM)
$1.80
Dividend yield
—
52W range
$51 – $66
Volume
2.0M
Biomarin Pharmaceutical Inc (BMRN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-50.09M | $-34.49M | $-9.18M | $87.73M | $18.75M | $18.75M | $17.61M | $-59.63M | $-73.54M | $-221.69M | $-227.84M | $-8.76M | $20.21M | $48.26M | $85.36M | $304.54M | $175.90M | $159.26M | $572.84M | $827.99M |
| Capital expenditures | $24.58M | $22.41M | $56.37M | $89.80M | $49.46M | $154.22M | $44.57M | $65.12M | $118.83M | $227.65M | $148.38M | $199.22M | $144.62M | $145.03M | $137.52M | $119.22M | $120.96M | $96.69M | $97.42M | $103.04M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $28.34M | $36.01M | $38.36M | $43.91M | $47.34M | $66.18M | $88.23M | $111.53M | $134.64M | $140.26M | $148.82M | $159.87M | $189.71M | $197.26M | $196.31M | $207.10M | $201.57M | $181.41M |
| Free cash flow | $-74.67M | $-56.91M | $-65.54M | $-2.07M | $-30.71M | $-135.47M | $-26.96M | $-124.76M | $-192.37M | $-449.34M | $-376.22M | $-207.98M | $-124.41M | $-96.76M | $-52.15M | $185.31M | $54.94M | $62.57M | $475.42M | $724.96M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $11.07M | $71.91M | $3.39M | $15.05M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $-79.09M | $-41.81M | $134.25M | $388.25M | $306.70M | $-478.45M | $11.29M | $189.70M | $-104.05M | $-56.54M | $211.71M | $-61.88M | — | — | — | — |